Gracia Marta I, Vazquez Patricia, Ibáñez-Pernía Yolanda, Pos Jeroen, Tawde Snehal
Imasde Agroalimentaria, S.L. C/Nápoles 3, 28224 Pozuelo de Alarcón, Spain.
Perstorp Animal Nutrition, Perstorp Waspik BV, 5165 NH Waspik, The Netherlands.
Animals (Basel). 2024 Feb 14;14(4):617. doi: 10.3390/ani14040617.
A novel combination of Butyric and Valeric acid glycerol esters with oregano oil in a dry powder form was evaluated for performance improvements in broilers. The dosing regimen (500 g/Ton feed in starter and grower; 250 g/Ton in finisher feed) was considered low compared to conventional practices using non-esterified Butyric and Valeric short-chain fatty acids (SCFA). Six trials were conducted at various trial facilities in Italy, United Kingdom, Spain, and Poland. Supplemented broilers weighed significantly more than the control birds at 28 days of age (+3.4%; 1459 g vs. 1412 g; = 0.0006) and at 42 days of age (+2.5%; 2834 g vs. 2763 g; = 0.0030). Supplementation significantly reduced mortality from 1.9% to 0.8% during the finisher phase (from 29 to 42 days of age); however, average mortality was 3.2% for the whole 42-day growth period and was not affected. Further, supplemented broilers grew more (66.4 vs. 64.5 g/day; = 0.0005), ate more feed (104.7 vs. 103.1 g/day; = 0.0473), converted feed significantly more efficiently (1.58 vs. 1.60; = 0.0072), leading to better EPEF value (410 vs. 389; = 0.0006) than the control broilers. Meta-analysed trial performance data for novel SCFA formulations such as these are not commonly available, and serve to facilitate efficacy determination from an end-user perspective. The use of short- and medium-chain fatty acid esters in optimal low-dose combinations to reliably augment gut health and performance appears promising in commercial broiler production, and may lead to further improvements in industry practices and reduced antibiotic use.
对一种新型的丁酸和戊酸甘油酯与干粉末形式牛至油的组合进行了评估,以观察其对肉鸡生产性能的改善情况。与使用未酯化的丁酸和戊酸短链脂肪酸(SCFA)的传统做法相比,给药方案(雏鸡和生长鸡阶段为500克/吨饲料;育肥鸡阶段为250克/吨)被认为剂量较低。在意大利、英国、西班牙和波兰的不同试验场所进行了六项试验。在28日龄时,添加该组合的肉鸡体重显著高于对照鸡(+3.4%;1459克对1412克;P = 0.0006),在42日龄时也是如此(+2.5%;2834克对2763克;P = 0.0030)。添加该组合显著降低了育肥阶段(29至42日龄)的死亡率,从1.9%降至0.8%;然而,整个42天的生长周期平均死亡率为3.2%,未受影响。此外,添加该组合的肉鸡生长更快(66.4对64.5克/天;P = 0.0005),采食量更多(104.7对103.1克/天;P = 0.0473),饲料转化率显著更高(1.58对1.60;P = 0.0072),导致经济效益指数(EPEF)值比对照肉鸡更好(410对389;P = 0.0006)。像这样的新型SCFA制剂的荟萃分析试验性能数据并不常见,有助于从终端用户角度确定其功效。在商业肉鸡生产中,以最佳低剂量组合使用短链和中链脂肪酸酯来可靠地增强肠道健康和生产性能似乎很有前景,可能会进一步改善行业做法并减少抗生素使用。